Fairvoy Private Wealth, LLC Astrazeneca PLC Transaction History
Fairvoy Private Wealth, LLC
- $364 Billion
- Q1 2025
A detailed history of Fairvoy Private Wealth, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fairvoy Private Wealth, LLC holds 4,923 shares of AZN stock, worth $347,268. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,923
Previous 4,606
6.88%
Holding current value
$347,268
Previous $302 Million
19.9%
% of portfolio
0.1%
Previous 0.08%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,428Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.03 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.87 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.51 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.25 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.21 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $219B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...